Differences between immunodeficient mice generated by classical gene targeting and CRISPR/Cas9-mediated gene knockout
Immunodeficient mice are widely used for pre-clinical studies to understand various human diseases. Here, we report the generation of four immunodeficient mouse models using CRISPR/Cas9 system without inserting any foreign gene sequences such as Neo R cassettes and their characterization. By elimina...
Gespeichert in:
Veröffentlicht in: | Transgenic research 2018-06, Vol.27 (3), p.241-251 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Immunodeficient mice are widely used for pre-clinical studies to understand various human diseases. Here, we report the generation of four immunodeficient mouse models using CRISPR/Cas9 system without inserting any foreign gene sequences such as Neo
R
cassettes and their characterization. By eliminating any possible effects of adding a Neo
R
cassette, our mouse models may allow us to better elucidate the in vivo functions of each gene. Our FVB-
Rag2
−/−
, B6-
Rag2
−/−
, and BALB/c-
Prkdc
−/−
mice showed phenotypes similar to those of the earlier immunodeficient mouse models, including a lack of mature B cells and T cells and an increase in the number of CD45
+
DX-5
+
natural killer cells. However, B6-
Il2rg
−/−
mice had a unique phenotype, with a lack of mature B cells, increased number of T cells, and decreased number of natural killer cells. Additionally, serum immunoglobulin levels in all four immunodeficient mouse models were significantly reduced when compared to those in wild-type mice with the exception of IgM in B6-
Il2r
g
−/−
mice. These results indicate that our immunodeficient mouse models are a robust tool for in vivo studies of the immune system and will provide new insights into the variation in phenotypic outcomes resulting from different gene-targeting methodologies. |
---|---|
ISSN: | 0962-8819 1573-9368 |
DOI: | 10.1007/s11248-018-0069-y |